Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies | Hematology, Transfusion and Cell Therapy
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Cancers | Free Full-Text | Immunoglobulin M Paraproteinaemias
Biochemical investigation of monoclonal gammopathies - Clinical Laboratory int.
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - The Lancet Haematology
Kappa and Lambda Light Chains - HealthTree for Myeloma
Making sense of serum protein bands - Best Tests July 2011
Polyclonal Antibodies - MyBioSource Learning Center
IFE Tutorial_03Oct
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
IJMS | Free Full-Text | Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View
Immunoglobulin Free Light Chains Kappa and Lambda Human ELISA | BioVendor R&D
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management - ScienceDirect
Laboratory assessment of multiple myeloma - ScienceDirect
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Following & Understanding Your Free Light Chain Test Results - YouTube
Utility of anti-immunoglobulin IgA, IgG, IgM, Kappa, Lambda - FITC (conjugate) cocktail in routine renal pathology practice | Surgical and Experimental Pathology | Full Text
Serum Protein Electrophoresis: Reference Range, Interpretation, Collection and Panels
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials | Leukemia